» Articles » PMID: 27660028

Angiotensin-(1-5), an Active Mediator of Renin-angiotensin System, Stimulates ANP Secretion Via Mas Receptor

Overview
Journal Peptides
Specialty Biochemistry
Date 2016 Sep 24
PMID 27660028
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Angiotensin-(1-5) [Ang-(1-5)], which is a metabolite of Angiotensin-(1-7) [Ang-(1-7)] catalyzed by angiotensin-converting enzyme (ACE), is a pentapeptide of the renin-angiotensin system (RAS). It has been reported that Ang-(1-7) and Ang-(1-9) stimulate the secretion of atrial natriuretic peptide (ANP) via Mas receptor (Mas R) and Ang II type 2 receptor (ATR), respectively. However, it still remains unknown whether Ang-(1-5) has a similar function to Ang-(1-7). We investigated the effect of Ang-(1-5) on ANP secretion and to define its signaling pathway using isolated perfused beating rat atria. Ang-(1-5) (0.3, 3, 10μM) stimulated high pacing frequency-induced ANP secretion in a dose-dependent manner. Ang-(1-5)-induced ANP secretion (3μM) was attenuated by the pretreatment with an antagonist of Mas R (A-779) but not by an antagonist of ATR (losartan) or ATR (PD123,319). An inhibitor for phosphatidylinositol 3-kinase (PI3K; wortmannin), protein kinase B (Akt; API-2), or nitric oxide synthase (NOS; L-NAME) also attenuated the augmentation of ANP secretion induced by Ang-(1-5). Ang-(1-5)-induced ANP secretion was markedly attenuated in isoproterenol-treated hypertrophied atria. The secretagogue effect of Ang-(1-5) on ANP secretion was similar to those induced by Ang-(1-9) and Ang-(1-7). These results suggest that Ang-(1-5) is an active mediator of renin-angiotensin system to stimulate ANP secretion via Mas R and PI3K-Akt-NOS pathway.

Citing Articles

Angiotensin Dysregulation in Patients with Arterial Aneurysms.

Leinweber M, Walter C, Assadian A, Kopecky C, Domenig O, Kovarik J Int J Mol Sci. 2025; 26(4).

PMID: 40003968 PMC: 11855860. DOI: 10.3390/ijms26041502.


Phosphoproteomics for studying signaling pathways evoked by hormones of the renin-angiotensin system: A source of untapped potential.

Souza-Silva I, Carregari V, Steckelings U, Verano-Braga T Acta Physiol (Oxf). 2025; 241(2):e14280.

PMID: 39821680 PMC: 11737475. DOI: 10.1111/apha.14280.


Characterizations of angiotensin-converting enzyme-2 (ACE2) peptidase activity.

Saulnier N, Thorne D, Bablu F, Suzuki A, Khan R, Oliveira K Arch Biochem Biophys. 2024; 761:110167.

PMID: 39349131 PMC: 11560506. DOI: 10.1016/j.abb.2024.110167.


Counter-regulatory RAS peptides: new therapy targets for inflammation and fibrotic diseases?.

Avila-Martinez D, Mixtega-Ruiz W, Hurtado-Capetillo J, Lopez-Franco O, Flores-Munoz M Front Pharmacol. 2024; 15:1377113.

PMID: 38666016 PMC: 11044688. DOI: 10.3389/fphar.2024.1377113.


Novel Approaches in Chronic Renal Failure without Renal Replacement Therapy: A Review.

Martinez-Hernandez S, Munoz-Ortega M, Avila-Blanco M, Medina-Pizano M, Ventura-Juarez J Biomedicines. 2023; 11(10).

PMID: 37893201 PMC: 10604533. DOI: 10.3390/biomedicines11102828.